# US 2021/0275241 A1 · Systems and Methods for Improved Treatment of Headache

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275241 A1
- Document ID: US20210275241A1
- Status: Published application
- Kind: A1
- Application number: 17/259,389
- Filed: 2019-07-22
- Published: 2021-09-09
- Earliest claimed: 2018-07-20
- Assignees: Arrinex, Inc.
- Applicants: Arrinex, Inc.
- Inventors: Brian Fahey; William Jason Fox; Bryant Lin; Vahid Saadat
- Web page: https://patentgrep.com/patent/US20210275241A1

## CPC

- A61B 18/0218: {with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip}
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61B 2018/00065: {porous}
- A61B 2018/00238: {porous}
- A61B 2018/00327: {Ear, nose or throat}
- A61B 2018/00345: {Vascular system}
- A61B 2018/00434: {Neural system}
- A61B 2018/00583: {Coblation, i.e. ablation using a cold plasma}
- A61B 2018/00916: {with means for switching or controlling the main function of the instrument or device}
- A61B 2018/0212: {using an instrument inserted into a body lumen, e.g. catheter}
- A61B 2018/0262: {using a circulating cryogenic fluid}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The present disclosure provides apparatuses and methods for treating conditions such as chronic daily headache, cluster headache, tension headache, migraine, or acute headache of a patient. In example methods, a cryotherapy element is introduced into the nasal cavity or pterygopalatine fossa to cool or cryoablate at least one of a nasal nerve tissue or nasal blood vessel. The cryotherapy element may be introduced into the nasal cavity in a collapsed position, and prior to cooling a target treatment site may be expanded to an expanded configuration.

## Claims

### Claim 1

A method for treating or preventing a chronic daily headache, cluster headache, tension headache, migraine, or acute headache of a patient, the method comprising:
advancing a non-penetrating cryotherapy element into a nasal cavity of a patient with the cryotherapy element in a first collapsed configuration;
contacting the cryotherapy element with a surface of a nasal cavity tissue without penetrating the nasal cavity tissue surface;
reconfiguring the cryotherapy element from the first collapsed configuration to a second expanded configuration; and
cryogenically cooling a target treatment site with the cryotherapy element in order to treat or prevent a chronic daily headache, cluster headache, tension headache, migraine, or acute headache, wherein the target treatment site comprises at least one nasal nerve tissue or nasal blood vessel.

### Claim 2 (depends on 1)

The method of claim 1, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element into the inferior meatus.

### Claim 3 (depends on 1)

The method of claim 1, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element into the superior meatus.

### Claim 4 (depends on 1)

The method of claim 1, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element into the middle meatus.

### Claim 5 (depends on 1, 2, 3, 4)

The method of any one of claims 1-4, wherein the nasal blood vessel is a sphenopalatine artery.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the nasal nerve tissue is a sphenopalatine ganglion, and wherein the sphenopalatine ganglion is cooled through a perpendicular plate of a palatine bone within a superior meatus between a middle turbinate and an anterior face of a sphenoid sinus.

### Claim 7 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the nasal nerve tissue is a posterior nasal nerve or an accessory posterior nasal nerve.

### Claim 8 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the nasal nerve tissue is a nerve branch originating from the sphenopalatine ganglion.

### Claim 9 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the nasal nerve tissue is an autonomic nerve branch.

### Claim 10 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the nasal nerve tissue is a parasympathetic nerve fiber.

### Claim 11 (depends on 10)

The method of claim 10, wherein the parasympathetic nerve fiber is a post-synaptic parasympathetic nerve fibers emerging from a sphenopalatine ganglion.

### Claim 12 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the nasal nerve tissue is a sensory nerve fiber.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein cryogenically cooling the target treatment site causes damage to mucosal tissue in the nasal cavity.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any one of claims 1-13, wherein cryogenically cooling the target treatment site causes a reduced blood flow in the nasal blood vessel.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method of any one of claims 1-14, further comprising applying pressure to the target treatment site with in order to reduce blood flow in the nasal blood vessel.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of any one of claims 1-15, wherein reconfiguring the cryotherapy element to the second expanded configuration and cryogenically cooling the target treatment site do not cause fracturing or puncturing of nasal bone, cartilage or mucosal tissue.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method of any one of claims 1-16, wherein while cryogenically cooling the target treatment site no portion of the cryotherapy element is within the pterygopalatine fossa.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any one of claims 1-17, wherein the cryotherapy element comprises an expandable structure, and
wherein cooling the target treatment site comprises inflating the expandable structure through evaporation of a cryogenic fluid within the expandable structure.

### Claim 19 (depends on 18)

The method of claim 18, wherein cooling the target treatment site comprises cryo-ablating at least one of the nasal blood vessel or nasal nerve tissue.

### Claim 20 (depends on 18, 19)

The method of any one of claims 18-19, wherein the expandable structure is porous and wherein cooling the target treatment site further comprises evaporation of the cryogenic fluid expelled through pores of the expandable structure.

### Claim 21 (depends on 18, 19, 20)

The method of any one of claims 18-20, wherein cooling the target treatment site with the cryotherapy element comprises placing a surface of the expandable structure against the target treatment site, and wherein the surface of the expandable structure is configured to provide uniform cooling across the target treatment site.

### Claim 22 (depends on 18, 19, 20, 21)

The method of any one of claims 18-21, wherein cooling the target treatment site with the cryotherapy element comprises placing a surface of the expandable structure against the target treatment site, and wherein the surface of the expandable structure is configured to provide a substantially uniform cryo-energy distribution along the nasal cavity tissue surface.

### Claim 23 (depends on 22)

The method of claim 22, wherein the expandable structure comprises a first thickness in a middle portion of the surface that is greater than a second thickness at an edge portion of the surface in order to provide uniform cryo-energy distribution along the nasal cavity tissue surface.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The method of any one of claims 1-23, wherein the cryotherapy element comprises a plurality of tine, wherein the tines, wherein transitioning from the first collapsed configuration to the second expanded configuration causes the tines to fan out, and wherein cooling the target treatment site with the cryotherapy element comprises expelling a cryogenic fluid from the tines onto the target treatment site.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element into a sphenoethmoidal recess.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element proximate to a superior turbinate.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element proximate to an anterior ethmoid nerve.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element into a maxillary sinus.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element into a choanal arch.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1-24, wherein advancing the cryotherapy element into the nasal cavity comprises advancing the cryotherapy element proximate to ethmoid foramina.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The method of any one of claims 1-30, wherein the nasal nerve tissue is a nerve branch originating from a trigeminal nerve.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 1-31, wherein cryogenically cooling the target treatment site causes cooling of a sphenoethmoidal recess.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method of any one of claims 1-32, wherein cryogenically cooling the target treatment site causes cooling of a region proximate to an anterior ethmoid nerve.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any one of claims 1-33, wherein cryogenically cooling the target treatment site causes cooling of a region proximate to a posterior ethmoid nerve.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any one of claims 1-34, wherein cryogenically cooling the target treatment site causes cooling of a region along an ethmoid bone proximate to ethmoid foramina.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any one of claims 1-35, wherein cryogenically cooling the target treatment site causes a reduced degree of trigeminal sensitization.

### Claim 37

A method for treating or preventing a chronic daily headache, cluster headache, tension headache, migraine, or acute headache of a patient, the method comprising:
advancing a cryotherapy element into a nasal cavity of a patient;
advancing at least a portion of the cryotherapy element into a pterygopalatine fossa of the patient; and
cryogenically cooling a target treatment site within the pterygopalatine fossa with the cryotherapy element in order to treat or prevent a chronic daily headache, cluster headache, tension headache, migraine, or acute headache, wherein the target treatment site comprises at least one nasal nerve tissue or nasal blood vessel.

### Claim 38 (depends on 37)

The method of claim 37, wherein the nasal blood vessel is a sphenopalatine artery.

### Claim 39 (depends on 37)

The method of claim 37, wherein the nasal nerve tissue is a sphenopalatine ganglion.

### Claim 40 (depends on 37)

The method of claim 37, wherein the nasal nerve tissue is a nerve branch originating from the sphenopalatine ganglion.

### Claim 41 (depends on 37)

The method of claim 37, wherein the nasal nerve tissue is an autonomic nerve branch.

### Claim 42 (depends on 37)

The method of claim 37, wherein the nasal nerve tissue is a parasympathetic nerve fiber.

### Claim 43 (depends on 37)

The method of claim 37, wherein the nasal nerve tissue is a sensory nerve fiber.

### Claim 44 (depends on 37, 38, 39, 40, 41, 42, 43)

The method of any one of claims 37-43, wherein cryogenically cooling the target treatment site causes a reduced blood flow in the nasal blood vessel.

### Claim 45

A method for treating or prevent a chronic daily headache, cluster headache, tension headache, migraine, or acute headache of a patient, the method comprising:
advancing a cryotherapy element into a mouth of a patient;
advancing at least a portion of the cryotherapy element into a pterygopalatine fossa of the patient; and
cryogenically cooling a target treatment site within the pterygopalatine fossa with the cryotherapy element in order to treat or prevent a chronic daily headache, cluster headache, tension headache, migraine, or acute headache, wherein the target treatment site comprises at least one nasal nerve tissue or nasal blood vessel.

### Claim 46 (depends on 45)

The method of claim 45, wherein the nasal blood vessel is a sphenopalatine artery.

### Claim 47 (depends on 45, 46)

The method of any one of claims 45-46, wherein the nasal nerve is a sphenopalatine ganglion.

### Claim 48 (depends on 45, 46, 47)

The method of any one of claims 45-47, wherein the nasal nerve is a nerve branch originating from the sphenopalatine ganglion.

### Claim 49 (depends on 45, 46)

The method of any one of claims 45-46, wherein the nasal nerve is an autonomic nerve branch.

### Claim 50 (depends on 45, 46)

The method of any one of claims 45-46, wherein the nasal nerve is a parasympathetic nerve fiber.

### Claim 51 (depends on 45, 46)

The method of any one of claims 45-46, wherein the nasal nerve is a sensory nerve fiber.

### Claim 52 (depends on 45, 46, 47, 48, 49, 50, 51)

The method of any one of claims 45-51, wherein cryogenically cooling the target treatment site causes a reduced blood flow in the nasal blood vessel.
